Archive for December, 2009

Ulcer Preventative May Raise Pneumonia Risks

Friday, December 25th, 2009

A popular stomach acid reducer greatly increases the risk of pneumonia in certain critically ill hospital patients, a new study has found.

Researchers at Wake Forest University School of Medicine in North Carolina analyzed the charts of 834 cardiothoracic surgery patients on breathing machines who were given stomach acid reducers to prevent stress ulcers. The patients were given either ranitidine (Zantac) or pantoprazole (Protonix). Both drugs reduce stomach acid, but pantoprazole is more powerful and is the drug of choice in many hospitals.

However, the study found that people given pantoprazole were three times more likely to develop hospital-acquired pneumonia than those given ranitidine. The findings were published recently in Chest.

“We conducted this study, in part, because we thought we were seeing more pneumonias than we were used to having,” Marc G. Reichert, pharmacy coordinator for surgery at Wake Forest University Baptist Medical Center and a co-author of the study, said in a university news release.

Hospital-acquired pneumonia — the leading cause of infection-related deaths in critically ill patients — increases hospital stays by an average of seven to nine days, adds to the overall costs of care and raises the risk for other complications.

People on breathing machines sometimes develop pneumonia when stomach secretions reflux into the lungs.

With Alcohol, Starting Young May Lead to Dependency

Friday, December 18th, 2009

Teens who start drinking before age 15 could jump-start any genetic conditions they might have that predispose them to developing alcohol dependency, according to an Australian study.

From a biological perspective, taking that first drink at a young age “may induce changes in the highly sensitive adolescent brain, which may also modify an individual’s subsequent genetic vulnerability to [alcohol dependence],” Arpana Agrawal, an assistant professor of psychiatry at Washington University School of Medicine and an author of the study, said in a university news release.

The findings, published online Sept. 18 and in the December print issue of Alcoholism: Clinical & Experimental Research, are based on a study of 6,257 adult twins.

The younger people were when they had their first drink, especially if that occurred before age 15, the more symptoms of alcohol dependency they developed, the study found. Early drinkers also tended to have an increased genetic vulnerability for alcohol.

Those who had their first drink later in life showed far fewer signs of alcohol dependency, despite the genetic predisposition, Agrawal noted.

This suggests that alcohol dependency among those who started drinking later, “while less common, are attributable to unique experiences of those individuals — for example, a traumatic life event,” she said.

Carol A. Prescott, a professor of psychology at the University of Southern California, said the findings had two possible conclusions. “Early drinking changes the course an individual is on, and is thus a direct cause of increased [alcohol dependency] risk, and early drinking is correlated with [alcohol dependency] risk and is thus an indirect indicator of … risk,” she said in the news release.

Agrawal said the findings should be used to discourage young people from experimenting with drinking early because such behavior might trigger an onset of alcohol abuse.

The researchers plan to do a similar study that looks at older and younger groups in Australia and the United States to try to duplicate their findings.

Childhood Stroke More Common Than Thought

Friday, December 11th, 2009

The incidence of stroke among American children could be two to four times greater than has commonly been estimated, a new study says.

Pediatric strokes are rare; even the new estimate puts its incidence at only 2.4 strokes per 100,000 person-years (person-years represent the number of years children were studied). But the report, published in the Sept. 17 online issue of Stroke, also cites five previous studies in which the estimated incidence ranged from .54 to 1.2 per 100,000 children per year.

“All those studies relied on billing coding to identify patients with stroke,” explained study author Dr. Heather J. Fullerton, director of the Pediatric Stroke and Cerebrovascular Disease Center at the University of California, San Francisco, Children’s Hospital. “Our study looked first at billing, and then at radiology reports.”

Fullerton and her colleagues looked at data on 2.3 million children up to the age of 19 who were enrolled in the Kaiser Permanente managed-care plan in northern California from 1993 to 2003. They searched for stroke cases listed by diagnostic code for billing purposes and also for reports indicating strokes in radiological studies, including computed tomography and MRI. The radiology reports yielded a higher incidence of stroke.

Estimates based on billing are not reliable for several reasons, Fullerton said. “Children who have strokes often are ill for other reasons, such as meningitis or congenital heart disease, so they are coded for that,” she said. “Also, coders apply the stroke diagnoses less often for children because they are perceived as rare events. Or they get nonspecific diagnoses.”

The concept that children simply don’t have strokes is widely prevalent, Fullerton noted. “Even among insurance companies, the impression seems to be that strokes don’t happen to children,” she said. “I have received calls from insurance companies questioning a diagnosis of stroke in a child.”

Dr. E. Steve Roach, director of pediatric neurology at Nationwide Children’s Hospital in Columbus, Ohio, who said, “I’ve been studying stroke in kids for 20 years,” added that “the new study confirms what I’ve been saying all that time. It’s just way, way underdiagnosed.”

Roach said he led two studies, one reported a decade ago, the other last year, that came to the same conclusion. “When we did a search of discharge records, a lot of them just did not show up,” he said.

“Most people, and even most doctors, can’t accept the idea that children have strokes,” Roach said. “It’s just a bias on the part of physicians that stroke just doesn’t occur in children.”

This new comparison of the two methods of identifying a pediatric stroke found that radiological evidence was much more sensitive than the billing code. The radiology method was far more sensitive (83 percent) than the billing code method (39 percent.)

The difference was even greater for strokes that occurred at the time of childbirth, with a sensitivity of 12 percent using the billing codes and 87 percent using radiological records.

But the study came with a word of caution. Because it was based on data from one health-care organization, it’s not clear whether the difference in incidence between billing codes and radiological findings will be found elsewhere, the report noted.

More studies in different populations are needed to firm up the finding, Fullerton said.

Failure to identify a childhood stroke properly might not be an issue for the child’s family, Fullerton said. “It is more an issue for those of us who investigate strokes,” she said. “When we try to identify pediatric strokes, it is important that we recognize that we could be missing a large chunk of cases.”

What does my medication look like?

Friday, December 4th, 2009

Sildenafil is available with a prescription under the brand names Viagra and Revatio. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.

Revatio 20 mg - white, film-coated round tablets

Viagra 25 mg - blue, film-coated tablets with a rounded-diamond shape

Viagra 50 mg - blue, film-coated tablets with a rounded-diamond shape

Viagra 100 mg - blue, film-coated tablets with a rounded-diamond shape
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. (’Multum’) is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum’s drug information does not endorse drugs, diagnose patients or recommend therapy. Multum’s drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.